L. Lee

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.

G. Batist, J. Gutheil, M. Nair, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.

G. Hortobagyi, V. Valero, D. Booser, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer.

S. Chan, F. Erdkamp, A. Płużańska, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression

Stephanie J. Lee, M. Flowers, E. Krakow, 2022, Transplantation and Cellular Therapy.

Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.

R. Pollard, J. Graybill, D. Mildvan, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

C. Nutting, S. Rottey, A. Bexon, 2014, Investigational New Drugs.